Eintrag weiter verarbeiten
Treatment of Malignant Pleural Effusion With the Trifunctional Antibody Catumaxomab (Removab) (Anti-EpCAM×Anti-CD3) : Results of a Phase 1/2 Study: Results of a Phase 1/2...
Gespeichert in: